Loading clinical trials...
Loading clinical trials...
Whole body cryotherpy (WBC) is a well-tolerated procedure that implies patients' exposition at a temperature of approximately -110 degrees. A considerable increase in the popularity of WBC has occurred in rheumatologic patients, despite a lack of evidences of its efficiency. Because of its interesting anti-inflammatory properties, the investigators think that WBC could be an alternative treatment to classical NSAIDs (Non Steroidal Anti Inflammatory Drugs) and corticosteroids, in patients suffering from axial spondyloarthritis. This is a proof of concept study.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Assistance Publique Hopitaux de Marseille
Marseille, France
Start Date
July 1, 2016
Primary Completion Date
September 18, 2018
Completion Date
October 28, 2022
Last Updated
November 10, 2022
36
ACTUAL participants
cryotherapy
OTHER
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT05094128
NCT05926453
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07018206